0NDG Stock Overview
Operates hospitals in Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
MEDICLIN Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.58 |
| 52 Week High | €2.58 |
| 52 Week Low | €2.58 |
| Beta | 0.26 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -26.66% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0NDG | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 0% | 0.2% | 0.2% |
| 1Y | n/a | -25.5% | 2.3% |
Return vs Industry: Insufficient data to determine how 0NDG performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how 0NDG performed against the UK Market.
Price Volatility
| 0NDG volatility | |
|---|---|
| 0NDG Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 4.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0NDG's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0NDG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 6,910 | Joachim Ramming | www.mediclin.de |
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, vascular medicine, otorhinolaryngology, cardiac medicine, rheumatology, pain medicine, trauma surgery, urology, and others.
MEDICLIN Aktiengesellschaft Fundamentals Summary
| 0NDG fundamental statistics | |
|---|---|
| Market cap | €113.05m |
| Earnings (TTM) | -€14.95m |
| Revenue (TTM) | €764.10m |
0.1x
P/S Ratio-7.6x
P/E RatioIs 0NDG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0NDG income statement (TTM) | |
|---|---|
| Revenue | €764.10m |
| Cost of Revenue | €618.32m |
| Gross Profit | €145.78m |
| Other Expenses | €160.73m |
| Earnings | -€14.95m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 04, 2024
| Earnings per share (EPS) | -0.31 |
| Gross Margin | 19.08% |
| Net Profit Margin | -1.96% |
| Debt/Equity Ratio | 46.7% |
How did 0NDG perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/10/06 14:37 |
| End of Day Share Price | 2024/07/09 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MEDICLIN Aktiengesellschaft is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Karl-Heinz Scheunemann | Landesbank Baden-Wuerttemberg Equity and Fixed Income Research |
| Klaus Schlote | Solventis Wertpapierhandelsbank GmbH |
| Nico Loechner | Solventis Wertpapierhandelsbank GmbH |